GFG Capital’s HCA Healthcare HCA Stock Holding History

GFG Capital’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-55	Closed	-$21.1K	–	178
2025 Q2	$21.1K	Buy	+55	New	+$19.8K	0.01%	156

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GFG Capital's HCA Position: Q3 2025 in Review

GFG Capital sold out of HCA Healthcare (HCA) in Q3 2025, closing a stake of 55 shares — an estimated $21.1K sold.

GFG Capital first reported a position in HCA in Q2 2025 and held it in 1 quarter. The position peaked at $21.1K in Q2 2025. 1,288 funds tracked by Wall St. Rank hold HCA as of Q3 2025.

GFG Capital reported no remaining HCA Healthcare position as of Q3 2025 after selling out during the quarter.
GFG Capital sold 55 HCA Healthcare shares in Q3 2025, an estimated $21.1K.
GFG Capital first reported a position in HCA Healthcare in Q2 2025 and held it in 1 quarter.
GFG Capital's HCA Healthcare position peaked at $21.1K in Q2 2025.
1,288 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2025.

Based on GFG Capital's 13F filing for Q3 2025, filed 7 Oct 2025.